HJM 13 Idaho House · 65th Legislature, 2nd Regular Session (2020)

HEALTH – Stating findings of the Legislature and requesting that Congress take action necessary to make buprenorphine more accessible to patients.

Bill status passed both 4 of 5 stages cleared
Introduction
Feb 2020
Committee Review
Feb 2020
House Passage
Mar 2020
Senate Passage
Feb 2020
Governor
Introduced Feb 12, 2020 Last action Mar 9, 2020
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
16
Key actions
3
Committee
3
Mar 3, 2020
Lower · Passed
Returned from Senate Passed; to JRA for Enrolling
lower
Feb 27, 2020
Lower · Passed
Reported out of Committee with Do Pass Recommendation; to 10th order; held one legislative day
lower
Feb 24, 2020
Introduced
Introduced, read first time; referred to: Health & Welfare
upper
Feb 18, 2020
Upper · Passed
Reported out of Committee with Do Pass Recommendation, Filed for Second Reading
upper
Feb 13, 2020
Committee
Reported Printed and Referred to Health & Welfare
lower
Feb 12, 2020
Introduced
Introduced, read first time, referred to JRA for Printing
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.